BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 16, 2014
View Archived Issues
A*STAR partners with Roche in cancer
Read More
Merck & Co. patents novel HIV integrase inhibitors
Read More
Actelion presents novel P2X7 receptor antagonists
Read More
Grant supports DiamiR's work on brain-enriched microRNA biomarkers for Parkinson's disease
Read More
Ratiopharm claims new MMF prodrugs
Read More
Almirall patents novel dual beta2 agonists and M3 antagonists
Read More
Serum peptide signature detects early-stage lung cancer
Read More
Gene signature correlated with prognosis in colorectal cancer
Read More
Novel agents for cancer and infections reported by the University of Washington
Read More
Purdue Pharma patents new Na(v)1.7 channel blockers
Read More
C4T discloses new cannabinoid CB2 receptor agonists
Read More
Takeda Pharmaceutical discloses novel DAAO inhibitors
Read More
Ventrus Biosciences becomes Assembly Biosciences
Read More
PharmaMar and Chugai enter into license agreement in Europe for Aplidin
Read More
Treatment with PF-05231023 improves lipid parameters in patients with type 2 diabetes
Read More
ZS Pharma completes enrollment in second phase III study of ZS-9 in hyperkalemia
Read More
Abbott to sell part of generics business to Mylan
Read More
AstraZeneca's proton pump inhibitor enters pediatric phase I/II clinical trial
Read More
BioChaperone Combo shows promising PK/PD profile in early clinical trials
Read More
Novartis collaborates with Banner Alzheimer's Institute on AD prevention study
Read More
SBIR grant supports Cel-Sci's development of LEAPS technology for RA
Read More
Neos Therapeutics reports phase III findings for NT-0102
Read More
FDA grants priority review to sNDA for simeprevir in combination with sofosbuvir
Read More
GSK and Theravance initiate phase III program of triple combination treatment for COPD
Read More
Nymox completes enrollment in second re-injection study of NX-1207 for BPH
Read More